# US 2024/0200088 A1 · Transgenic Plants Comprising Myoglobin and Methods for Producing Myoglobin in Transgenic Plants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200088 A1
- Document ID: US20240200088A1
- Status: Published application
- Kind: A1
- Application number: 18/286,484
- Filed: 2022-04-13
- Published: 2024-06-20
- Earliest claimed: 2021-04-13
- Applicants: Kyomei Ltd.
- Inventors: Kyoko MORIMOTO; Yisroel Meir WACHS
- Web page: https://patentgrep.com/patent/US20240200088A1

## CPC

- C12N 15/8257: {for the production of primary gene products, e.g. pharmaceutical products, interferon}
- C07K 14/4716: {Muscle proteins, e.g. myosin, actin}
- C07K 14/805: Haemoglobins; Myoglobins
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This disclosure provides methods and materials for producing a transgenic plant expressing a myoglobin gene, producing myoglobin protein in the transgenic plant, and isolating the myoglobin protein from the transgenic plants.

## Claims

### Claim 1

A transgenic plant, wherein the transgenic plant comprises at least one chloroplast with one or more recombinant nucleic acid sequences expressing a myoglobin gene encoding a myoglobin protein.

### Claim 2 (depends on 1)

The transgenic plant of claim 1, wherein the one or more recombinant nucleic acid sequences is integrated into the chloroplast DNA of the transgenic plant, and/or wherein the one or more recombinant nucleic acid sequences is stably integrated into the chloroplast DNA of the transgenic plant.

### Claim 3 (depends on 1)

The transgenic plant of claim 1, wherein the transgenic plant comprises at least about 10 copies, at least about 100 copies, at least about 1,000 copies, at least about 5,000 copies, at least about 10,000 copies, at least about 20,000 copies, at least about 30,000 copies, at least about 40,000 copies, or at least about 50,000 copies of the one or more recombinant nucleic acid sequences.

### Claim 4 (depends on 1)

The transgenic plant of claim 1, wherein the one or more recombinant nucleic acid sequences further comprises:
(a) one or more selectable markers, wherein the one or more selectable markers are optionally removable;
(b) one or more genes encoding one or more enzymes in the heme biosynthesis pathway;
(c) one or more targeting sequences for homologous recombination in the host transgenic plant chloroplast DNA.

### Claim 5 (depends on 1)

The transgenic plant of claim 1, wherein the transgenic plant is: (a) a stable, homoplasmic transformant; or (b) a stable heteroplasmic transformant.

### Claim 6 (depends on 1)

The transgenic plant of claim 1, wherein the myoglobin gene is a bovine myoglobin gene (for example, bison, buffalo, cow, goat, sheep, or yak), an avian myoglobin gene (for example, chicken, duck, goose, guinea fowl, quail, pigeon, or turkey), a suine myoglobin gene (for example, boar or pig), or a fish myoglobin (for example, tuna, salmon, or eel).

### Claim 7 (depends on 1)

The transgenic plant of claim 1, wherein the myoglobin gene is selected from Table 1 and/or wherein the myoglobin gene encodes a myoglobin protein selected from SEQ ID NO's 1-35.

### Claim 8 (depends on 1)

The transgenic plant of claim 1, wherein the myoglobin gene comprises a codon-optimized myoglobin gene, and wherein the codon-optimized myoglobin gene is codon-optimized for expression in the transgenic plant.

### Claim 9 (depends on 1)

The transgenic plant of claim 1, wherein the myoglobin gene is operably linked to at least one promoter.

### Claim 10 (depends on 1)

The transgenic plant of claim 1, wherein the transgenic plant is a grass (for example, a barely, a corn, a maize, an oat, a silvergrass, a sugarcane, a rice, a rye, or a wheat), a legume (for example, an alfalfa, a bean, a chickpea, a clover, a lentil, a pea, or a peanut), a nightshade (for example, an eggplant, a pepper, a potato, a tobacco, or a tomato), an aster (for example, a lettuce, a chamomile, an artichoke, an endive, a lavender, a cotton, a sunflower), or an alga, a moss, or a liverwort.

### Claim 11 (depends on 10)

The transgenic plant of claim 10, wherein the transgenic plant is an aster, and the aster is a lettuce plant (i.e., a Lactuca species).

### Claim 12 (depends on 10)

The transgenic plant of claim 10, wherein the transgenic plant is a legume.

### Claim 13 (depends on 10)

The transgenic plant of claim 10, wherein the transgenic plant is a nightshade, and the nightshade is a tobacco plant (i.e., a Nicotiana species).

### Claim 14 (depends on 1)

The transgenic plant of claim 1, wherein the transgenic plant comprises a knock-down or knock-out of one or more genes encoding magnesium chelatase enzymes.

### Claim 15 (depends on 1)

The transgenic plant of claim 1, wherein the myoglobin protein comprises at least about 0.1%, at least about 1.0%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% of the total soluble protein from the transgenic plant.

### Claim 16 (depends on 1)

A method of producing a myoglobin protein, wherein the method comprises growing the transgenic plant of claim 1 and isolating the myoglobin protein from the transgenic plant.

### Claim 17

A method of producing a myoglobin protein in a transgenic plant, wherein the method comprises:
(a) growing the transgenic plant, wherein the transgenic plant comprises at least one chloroplast with one or more recombinant nucleic acid sequences expressing a myoglobin gene encoding the myoglobin protein, and
(b) isolating the myoglobin protein from the transgenic plant.

### Claim 18 (depends on 17)

The method of claim 17, wherein the one or more recombinant nucleic acid sequences is integrated into the chloroplast DNA of the transgenic plant, and/or wherein the one or more recombinant nucleic acid sequences is stably integrated into the chloroplast DNA of the transgenic plant.

### Claim 19 (depends on 17)

The method of claim 17, wherein the transgenic plant comprises at least about 10 copies, at least about 100 copies, at least about 1,000 copies, at least about 5,000 copies, at least about 10,000 copies, at least about 20,000 copies, at least about 30,000 copies, at least about 40,000 copies, or at least about 50,000 copies of the one or more recombinant nucleic acid sequences.

### Claim 20 (depends on 17)

The method of claim 17, wherein the one or more recombinant nucleic acid sequences further comprises:
(a) one or more selectable markers, wherein the one or more selectable markers are optionally removable;
(b) one or more genes encoding one or more enzymes in the heme biosynthesis pathway; and/or
(c) one or more targeting sequences for homologous recombination in the host transgenic plant chloroplast DNA.

### Claim 21 (depends on 17)

The method of claim 17, wherein the transgenic plant is: (a) a stable, homoplasmic transformant; or (b) a stable heteroplasmic transformant.

### Claim 22 (depends on 17)

The method of claim 17, wherein the myoglobin gene is a bovine myoglobin gene (for example, bison, buffalo, cow, goat, sheep, or yak), an avian myoglobin gene (for example, chicken, duck, goose, guinea fowl, quail, pigeon, or turkey), a suine myoglobin gene (for example, boar or pig), or a fish myoglobin (for example, tuna, salmon, or eel).

### Claim 23 (depends on 17)

The method of claim 17, wherein the myoglobin gene is selected from Table 1 and/or wherein the myoglobin gene encodes a myoglobin protein selected from SEQ ID NO's 1-35.

### Claim 24 (depends on 17)

The method of claim 17, wherein the myoglobin gene comprises a codon-optimized myoglobin gene, wherein the codon-optimized myoglobin gene is codon-optimized for expression in the transgenic plant.

### Claim 25 (depends on 17)

The method of claim 17, wherein the myoglobin gene is operably linked to at least one promoter.

### Claim 26 (depends on 17)

The method of claim 17, wherein the transgenic plant is a grass (for example, a barely, a corn, a maize, an oat, a silvergrass, a sugarcane, a rice, a rye, or a wheat), a legume (for example, an alfalfa, a bean, a chickpea, a clover, a lentil, a pea, or a peanut), a nightshade (for example, an eggplant, a pepper, a potato, a tobacco, or a tomato), an aster (for example, a lettuce, a chamomile, an artichoke, an endive, a lavender, a cotton, a sunflower), or an alga, a moss, or a liverwort.

### Claim 27 (depends on 26)

The method of claim 26, wherein the transgenic plant is an aster, and the aster is a lettuce plant (i.e., a Lactuca species).

### Claim 28 (depends on 26)

The method of claim 26, wherein the transgenic plant is a legume.

### Claim 29 (depends on 26)

The method of claim 26, wherein the transgenic plant is a nightshade, and the nightshade is a tobacco plant (i.e., a Nicotiana species)

### Claim 30 (depends on 29)

The method of claim 29, wherein the transgenic plant comprises a knock-down or knock-out of one or more genes encoding magnesium chelatase enzymes.

### Claim 31 (depends on 17)

The method of claim 17, wherein the myoglobin protein comprises at least about 0.1%, at least about 1.0%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% of the total soluble protein from the transgenic plant.

### Claim 32

A recombinant nucleic acid sequence comprising a myoglobin gene encoding a myoglobin protein, wherein the myoglobin gene is operably linked to at least one promoter.

### Claim 33 (depends on 32)

The recombinant nucleic acid sequence of claim 32, wherein the recombinant nucleic acid sequence further comprises:
(a) one or more selectable markers, wherein the one or more selectable markers are optionally removable;
(b) one or more genes encoding one or more enzymes in the heme biosynthesis pathway; and/or
(c) one or more targeting sequences for homologous recombination in the transgenic plant chloroplast DNA.

### Claim 34 (depends on 32)

The recombinant nucleic acid sequence of claim 32, wherein the myoglobin gene is a bovine myoglobin gene (for example, bison, buffalo, cow, goat, sheep, or yak), an avian myoglobin gene (for example, chicken, duck, goose, guinea fowl, quail, pigeon, or turkey), a suine myoglobin gene (for example, boar or pig), or a fish myoglobin (for example, tuna, salmon, or eel).

### Claim 35 (depends on 32)

The recombinant nucleic acid sequence of claim 32, wherein the myoglobin gene selected from Table 1 and/or wherein the myoglobin gene encodes a myoglobin protein selected from SEQ ID NO's 1-35.

### Claim 36 (depends on 32)

The recombinant nucleic acid sequence of claim 32, wherein the myoglobin gene comprises a codon-optimized myoglobin gene, wherein the codon-optimized myoglobin gene is codon-optimized for expression in a transgenic plant.

### Claim 37 (depends on 32)

A transgenic plant comprising the recombinant nucleic acid sequence of claim 32.

### Claim 38 (depends on 37)

The transgenic plant of claim 37, wherein the recombinant nucleic acid sequence is integrated into the chloroplast DNA of the transgenic plant, and/or wherein the recombinant nucleic acid sequence is stably integrated into the chloroplast DNA of the transgenic plant.

### Claim 39 (depends on 37)

The transgenic plant of claim 37, wherein the transgenic plant comprises at least about 10 copies, at least about 100 copies, at least about 1,000 copies, at least about 5,000 copies, at least about 10,000 copies, at least about 20,000 copies, at least about 30,000 copies, at least about 40,000 copies, or at least about 50,000 copies of the one or more recombinant nucleic acid sequences.

### Claim 40 (depends on 37)

The transgenic plant of claim 37, wherein the transgenic plant is a grass (for example, a barely, a corn, a maize, an oat, a silvergrass, a sugarcane, a rice, a rye, or a wheat), a legume (for example, an alfalfa, a bean, a chickpea, a clover, a lentil, a pea, or a peanut), a nightshade (for example, an eggplant, a pepper, a potato, a tobacco, or a tomato), an aster (for example, a lettuce, a chamomile, an artichoke, an endive, a lavender, a cotton, a sunflower), or an alga, a moss, or a liverwort.

### Claim 41 (depends on 40)

The transgenic plant of claim 40, wherein the transgenic plant is an aster, and the aster is a lettuce plant (i.e., a Lactuca species).

### Claim 42 (depends on 40)

The transgenic plant of claim 40, wherein the transgenic plant is a legume.

### Claim 43 (depends on 40)

The transgenic plant of claim 40, wherein the transgenic plant is a nightshade, and the nightshade is a tobacco plant (i.e., a Nicotiana species).

### Claim 44 (depends on 43)

The transgenic plant of claim 43, wherein the transgenic plant comprises a knock-down or knock-out of one or more genes encoding magnesium chelatase enzymes.

### Claim 45 (depends on 37)

The transgenic plant of claim 37, wherein the myoglobin protein comprises at least about 0.1%, at least about 1.0%, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% of the total soluble protein from the transgenic plant.
